Kolbot By

Director Técnico/Científico/I+D en ALUMIS INC. .

Health Technology

Consumer Services

Perfil

Kolbot By currently works at Alumis, Inc., as Senior Vice President & Head-Technical Operations from 2022.
Dr. By also formerly worked at Rain Oncology, Inc., as Senior Vice President-Technical Operations from 2021 to 2022 and Principia Biopharma, Inc., as Vice President-Chemical Development.
Dr. By received his doctorate degree from the University of California, Davis and undergraduate degree from the University of California, Santa Barbara.

Cargos activos de Kolbot By

Empresas	Cargo	Inicio
ALUMIS INC.	Director Técnico/Científico/I+D	01/01/2022

Todos los cargos activos de Kolbot By

Antiguos cargos conocidos de Kolbot By.

Empresas	Cargo	Fin
RAIN ONCOLOGY INC.	Director Técnico/Científico/I+D	01/01/2022
PRINCIPIA BIOPHARMA INC.	Corporate Officer/Principal	-

Ver el detalle de la experiencia de Kolbot By.

Formación de Kolbot By.

Experiencias
Funciones ocupadas

Activas

Inactivas

Empresas cotizadas

Empresas privadas

Ver el detalle de la experiencia de Kolbot By.

Relaciones

Relaciones de 1er grado

Empresas vinculadas al 1er grado

Hombre

Mujer

Administradores

Ejecutivos

Consultar la red personal

Empresas relacionadas

Empresas privadas	5
Principia Biopharma, Inc. Principia Biopharma, Inc. Pharmaceuticals: MajorHealth Technology Operates as a R&D driven and AI-powered biopharma company	Health Technology
University of California, Davis University of California, Davis Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
University of California, Santa Barbara University of California, Santa Barbara Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
Rain Oncology, Inc. Rain Oncology, Inc. BiotechnologyHealth Technology Operates as a clinical-stage precision oncology company that develops therapeutics for cancer patients	Health Technology
Alumis, Inc. Alumis, Inc. Pharmaceuticals: MajorHealth Technology Engages in research and development of medicines for autoimmune disorders	Health Technology